DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,548 | +6.6% | 764 | +3.1% | 0.05% | +10.4% |
| Q2 2023 | $177,840 | -4.8% | 741 | 0.0% | 0.05% | -7.7% |
| Q1 2023 | $186,762 | -5.0% | 741 | 0.0% | 0.05% | -8.8% |
| Q4 2022 | $196,676 | +3.0% | 741 | 0.0% | 0.06% | -9.5% |
| Q3 2022 | $191,000 | +1.6% | 741 | 0.0% | 0.06% | +8.6% |
| Q2 2022 | $188,000 | -13.4% | 741 | 0.0% | 0.06% | +1.8% |
| Q1 2022 | $217,000 | -8.1% | 741 | +3.2% | 0.06% | -1.7% |
| Q4 2021 | $236,000 | +7.8% | 718 | 0.0% | 0.06% | -4.9% |
| Q3 2021 | $219,000 | +72.4% | 718 | +27.3% | 0.06% | +69.4% |
| Q1 2021 | $127,000 | +5.0% | 564 | 0.0% | 0.04% | -14.3% |
| Q3 2020 | $121,000 | +49.4% | 564 | 0.0% | 0.04% | +44.8% |
| Q3 2019 | $81,000 | +72.3% | 564 | +2.2% | 0.03% | +45.0% |
| Q3 2017 | $47,000 | 0.0% | 552 | 0.0% | 0.02% | -4.8% |
| Q2 2017 | $47,000 | – | 552 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |